The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
CD4+CD25high T Cells Are Enriched in the Tumor and Peripheral Blood of Prostate Cancer Patients
Open accessAbstract
In this study, we investigated whether CD4+CD25high regulatory T cells (Treg) are increased in the tumor tissue and peripheral blood of early-stage prostate cancer patients undergoing prostatectomy. We show that the prevalence of CD4+CD25high T cells inside the prostate was significantly higher in the tumor compared with benign tissue from the same prostate. Furthermore, the frequency of CD4+CD25high T cells in peripheral blood was significantly higher in prostate cancer patients compared with normal donors. A proportion of the CD4+CD25high T cells was also shown to be glucocorticoid-induced TNF receptor, ICOS, and FOXP3 positive. Moreover, CD4+CD25+ T cells from blood and supernatants from cultured prostate tumor tissue samples exhibited immunosuppressive function in vitro. Furthermore, supernatants from cultured prostate tissue samples and prostate cancer ascites fluid induced migration of CD4+CD25+ T cells and were shown to contain the regulatory T cell chemokine CCL22 by ELISA. Our findings indicate that Tregs are an important cellular component of early-stage prostate tumors, and thus new therapeutic strategies aimed at inhibition or depletion of Tregs may improve prostate cancer immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
Greenwald, R. J., Freeman, G. J., & Sharpe, A. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115611 · Cited by 2,318
CD4+CD25high Regulatory Cells in Human Peripheral Blood
Baecher-Allan, C., Brown, J. A., Freeman, G. J., & Hafler, D. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1245 · Cited by 1,859
Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L., & Powrie, F. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.7.995 · Cited by 1,615
Liyanage, U. K., Moore, T. T., Joo, H.-G., Tanaka, Y., Herrmann, V., Doherty, G., Drebin, J. A., Strasberg, S. M., Eberlein, T. J., Goedegebuure, P. S., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2756 · Cited by 1,467
CD4+CD25+ Immunoregulatory T Cells
McHugh, R. S., Whitters, M. J., Piccirillo, C. A., Young, D. A., Shevach, E. M., Collins, M., & Byrne, M. C. (2002) · Immunity · doi:10.1016/s1074-7613(02)00280-7 · Cited by 1,395
Role of LAG-3 in Regulatory T Cells
Huang, C.-T., Workman, C. J., Flies, D., Pan, X., Marson, A. L., Zhou, G., Hipkiss, E. L., Ravi, S., Kowalski, J., Levitsky, H. I., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.010 · Cited by 1,325
Woo, E. Y., Chu, C., Goletz, T. J., Schlienger, K., Yeh, H., Coukos, G., Rubin, S. C., Kaiser, L. R., & June, C. H. (2001) · PubMed · Cited by 1,108
Sutmuller, R. P. M., van Duivenvoorde, L. M., van Elsas, A., Schumacher, T. N. M., Wildenberg, M. E., Allison, J. P., Toes, R. E. M., Offringa, R., & Melief, C. J. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.823 · Cited by 1,008
Dannull, J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25947 · Cited by 989
Iellem, A., Mariani, M., Lang, R., Recalde, H., Panina-Bordignon, P., Sinigaglia, F., & D'Ambrosio, D. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.847 · Cited by 914
Regulatory T cells and mechanisms of immune system control
O'Garra, A., & Vieira, P. (2004) · Nature Medicine · doi:10.1038/nm0804-801 · Cited by 810
Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivo
Chen, M.-L., Pittet, M. J., Gorelik, L., Flavell, R. A., Weissleder, R., von Boehmer, H., & Khazaie, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408197102 · Cited by 806
Viguier, M., Lemaître, F., Verola, O., Cho, M.-S., Gorochov, G., Dubertret, L., Bachelez, H., Kourilsky, P., & Ferradini, L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1444 · Cited by 686
Ormandy, L. A., Hillemann, T., Wedemeyer, H., Manns, M. P., Greten, T. F., & Korangy, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3232 · Cited by 642
Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level
Roncador, G., Brown, P. J., Maestre, L., Hue, S., Martínez-Torrecuadrada, J. L., Ling, K.-L., Pratap, S., Toms, C., Fox, B. C., Cerundolo, V., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200526189 · Cited by 592
Self-citationTumor-Specific Human CD4+ Regulatory T Cells and Their Ligands
Wang, H. Y., Lee, D. A., Peng, G., Guo, Z., Li, Y., Kiniwa, Y., Shevach, E. M., & Wang, R.-F. (2004) · Immunity · doi:10.1016/s1074-7613(03)00359-5 · Cited by 515
Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma
Marshall, N. A., Christie, L. E., Munro, L. R., Culligan, D. J., Johnston, P. W., Barker, R. N., & Vickers, M. A. (2004) · Blood · doi:10.1182/blood-2003-07-2594 · Cited by 509
Sasada, T., Kimura, M., Yoshida, Y., Kanai, M., & Takabayashi, A. (2003) · Cancer · doi:10.1002/cncr.11618 · Cited by 484
Dendritic cells as a tool to induce anergic and regulatory T cells
Jonuleit, H., Schmitt, E., Steinbrink, K., & Enk, A. H. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01952-4 · Cited by 464
Zou, L., Barnett, B., Safah, H., LaRussa, V. F., Evdemon-Hogan, M., Mottram, P., Wei, S., David, O., Curiel, T. J., & Zou, W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1987 · Cited by 456
Álvaro, T., Lejeune, M., Salvadó, M. T., Bosch, R., García, J. F., Jaén, J., Banham, A. H., Roncador, G., Montalbán, C., & Piris, M. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1869 · Cited by 450
Self-citationInterleukin 2 regulates its own receptors.
Smith, K. A., & Cantrell, D. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.3.864 · Cited by 406
Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers
Bronte, V., Kasic, T., Gri, G., Gallana, K., Borsellino, G., Marigo, I., Battistini, L., Iafrate, M., Prayer-Galetti, T., Pagano, F., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042028 · Cited by 396
Agnello, D., Lankford, C. S. R., Bream, J., Morinobu, A., Gadina, M., O'Shea, J. J., & Frucht, D. M. (2003) · Journal of Clinical Immunology · doi:10.1023/a:1023381027062 · Cited by 378
Kuniyasu, Y., Takahashi, T., Itoh, M., Shimizu, J., Toda, G., & Sakaguchi, S. (2000) · International Immunology · doi:10.1093/intimm/12.8.1145 · Cited by 290
Schaefer, C., Kim, G. G., Albers, A., Hoermann, K., Myers, E. N., & Whiteside, T. L. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602407 · Cited by 271
IL-6: Insights into Novel Biological Activities
Barton, B. E. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4420 · Cited by 269 · cited 1×
“Both IL-4 and IL-6 have been shown to have some immunosuppressive properties (40, 41); however, because they appear in similar levels in both benign and PC supernatants this cannot account for the higher suppression seen with the PC supernatant (Fig.”
BackgroundCompromised lymphocytes infiltrate hepatocellular carcinoma: The role of T‐regulatory cells†‡
Unitt, E., Rushbrook, S. M., Marshall, A., Davies, S., Gibbs, P., Morris, L. S., Coleman, N., & Alexander, G. J. M. (2005) · Hepatology · doi:10.1002/hep.20644 · Cited by 267
Vesalainen, S., Lipponen, P., Talja, M., & Syrjänen, K. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)e0159-2 · Cited by 254
Löhning, M., Hutloff, A., Kallinich, T., Mages, H. W., Bonhagen, K., Radbruch, A., Hamelmann, E., & Kroczek, R. A. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20020632 · Cited by 253
Tanaka, H., Tanaka, J., Kjaergaard, J., & Shu, S. (2002) · Journal of Immunotherapy · doi:10.1097/00002371-200205000-00003 · Cited by 206
Cornerstone of peripheral tolerance: naturally occurring CD4+CD25+ regulatory T cells
Piccirillo, C. A., & Thornton, A. M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.04.009 · Cited by 166
Wang, H. Y., Peng, G., Guo, Z., Shevach, E. M., & Wang, R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2661 · Cited by 157
PHENOTYPIC CHARACTERISATION OF THE DENDRITIC CELL INFILTRATE IN PROSTATE CANCER
Troy, A., DAVIDSON, P., Atkinson, C. H., & Hart, D. N. J. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)63093-3 · Cited by 151
Immune recognition of self in immunity against cancer
Houghton, A. N., & Guevara-Patino, J. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22685 · Cited by 150
Definition of target antigens for naturally occurring CD4+ CD25+ regulatory T cells
Nishikawa, H., Kato, T., Tawara, I., Saito, K., Ikeda, H., Kuribayashi, K., Allen, P. M., Schreiber, R. D., Sakaguchi, S., Old, L. J., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041959 · Cited by 130
McArdle, P., Canna, K., McMillan, D. C., McNicol, A. M., Campbell, R., & Underwood, M. A. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601943 · Cited by 124
Fatal attraction: tumors beckon regulatory T cells
Shevach, E. M. (2004) · Nature Medicine · doi:10.1038/nm0904-900 · Cited by 121
Banz, A., Pontoux, C., & Papiernik, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.2.750 · Cited by 114
Kalamasz, D., Long, S. A., Taniguchi, R. T., Buckner, J. H., BERENSON, R. J., & Bonyhadi, M. L. (2004) · Journal of Immunotherapy · doi:10.1097/00002371-200409000-00010 · Cited by 111
Irani, J., Goujon, J., Ragni, E., Peyrat, L., Hubert, J., Saint, F., & Mottet, N. (1999) · Urology · doi:10.1016/s0090-4295(99)00152-1 · Cited by 107
Kawaida, H., Kono, K., Takahashi, A., Sugai, H., Mimura, K., Miyagawa, N., Omata, H., Ooi, A., & Fujii, H. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2004.10.004 · Cited by 105
Voo, K. S., Peng, G., Guo, Z., Fu, T., Li, Y., Frappier, L., & Wang, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2552 · Cited by 92
Do CD4+CD25+ Immunoregulatory T Cells Hinder Tumor Immunotherapy?
Antony, P. A., & Restifo, N. P. (2002) · Journal of Immunotherapy · doi:10.1097/00002371-200205000-00002 · Cited by 69
Altered Immunity Accompanies Disease Progression in a Mouse Model of Prostate Dysplasia
Tien, A. H., Xu, L., & Helgason, C. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3271 · Cited by 40
STRAVODIMOS, K. G., Constantinides, C. A., MANOUSAKAS, T., Pavlaki, C., Pantazopoulos, D., Giannopoulos, A., & Dimopoulos, C. (2000) · PubMed · Cited by 33
Prostate Specific Antigen Inhibits Immune Responses In Vitro: A Potential Role In Prostate Cancer
KENNEDY-SMITH, A. G., McKenzie, J. L., Owen, M. C., Davidson, P. J. T., Vučković, S., & Hart, D. N. J. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)64738-6 · Cited by 33
Technology Insight: vaccine therapy for prostate cancer
Vieweg, J., & Dannull, J. (2005) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0079 · Cited by 22
Therapeutic vaccines for prostate cancer: a review of clinical data.
Arlen, P. M., & Gulley, J. L. (2005) · PubMed · Cited by 15
Presence and specificity of tumor associated lymphocytes from ascites fluid in prostate cancer
Özenci, V., Miller, A. M., Palmborg, A., Egevad, L., Jaremko, G., Kälkner, K. M., & Pisa, P. (2005) · The Prostate · doi:10.1002/pros.20229 · Cited by 7
Self-citationHsing (1996) · doi:10.1002/(sici)1097-0215(19960208)65:4 · Cited by 1
Cited by
Inflammation in prostate carcinogenesis
De Marzo, A. M., Platz, E. A., Sutcliffe, S., Xu, J., Grönberg, H., Drake, C. G., Nakai, Y., Isaacs, W. B., & Nelson, W. G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2090 · Cited by 1,621
Hiam-Galvez, K. J., Allen, B. M., & Spitzer, M. H. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00347-z · Cited by 1,400
Hendry, S., Salgado, R., Gevaert, T., Russell, P. A., John, T., Thapa, B., Christie, M., van de Vijver, K., Estrada, M. V., Gonzalez-Ericsson, P. I., et al. (2017) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000161 · Cited by 799
Gobert, M., Treilleux, I., Bendriss-Vermare, N., Bachelot, T., Goddard-Leon, S., Arfi, V., Biota, C., Doffin, A. C., Durand, I., Olive, D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2360 · Cited by 758
Prostate cancer and inflammation: the evidence
Sfanos, K. S., & De Marzo, A. M. (2012) · Histopathology · doi:10.1111/j.1365-2559.2011.04033.x · Cited by 612
Metadata
- Authors
- Miller, A. M., Lundberg, K., Özenci, V., Banham, A. H., Hellström, M., Egevad, L., & Pisa, P.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-11
- Volume
- 177
- Issue
- 10
- Pages
- 7398-7405
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1599507531
- Cited by
- 421
- References
- 57
- FWCI
- 9.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.